Soligenix, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
SNGX
Soligenix, INCDEFA14A: Soligenix, Inc. Sets Date for 2025 Annual Meeting, Outlines Key Proposals for Stockholder Vote
Soligenix, Inc. announces its 2025 Annual Meeting of Stockholders to be held on June 20, 2025, outlining proposals including the election of directors, approval of the 2025 Equity Incentive Plan, and ratification of the independent auditor.
NASDAQ
SNGX
Soligenix, INCSoligenix has released its proxy statement, urging stockholders to vote on key proposals including the election of directors, approval of the 2025 Equity Incentive Plan, and executive compensation.
NASDAQ
SNGX
Soligenix, INCSoligenix, Inc. reminds shareholders to participate in the Annual Meeting of Shareholders by voting through www.proxyvote.com or by phone before the deadline.
NASDAQ
SNGX
Soligenix, INCSoligenix reminds shareholders to vote before the upcoming Annual Meeting of Shareholders.
NASDAQ
SNGX
Soligenix, INCSoligenix, Inc. reminds shareholders to participate in the Annual Meeting of Shareholders by voting via www.proxyvote.com or phone before the deadline.
NASDAQ
SNGX
Soligenix, INCSoligenix encourages shareholders to participate in the Annual Meeting of Shareholders by voting their shares.
NASDAQ
SNGX
Soligenix, INCSoligenix encourages shareholders to participate in the Annual Meeting of Shareholders on May 15, 2024, by voting their shares via www.proxyvote.com or phone.
NASDAQ
SNGX
Soligenix, INCSoligenix is asking stockholders to approve a reverse stock split to meet Nasdaq's minimum bid price requirement and is advancing its rare disease pipeline.